ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	16/154	191/7206	2.73438812992e-06
ko04380	Osteoclast differentiation	13/154	134/7206	4.97257240406e-06
ko04621	NOD-like receptor signaling pathway	14/154	157/7206	5.75130617782e-06
ko04668	TNF signaling pathway	12/154	120/7206	8.533262634e-06
ko05164	Influenza A	14/154	167/7206	1.17808960905e-05
ko04650	Natural killer cell mediated cytotoxicity	10/154	97/7206	3.7888855271e-05
ko05167	Kaposi's sarcoma-associated herpesvirus infection	14/154	191/7206	5.33264295315e-05
ko05150	Staphylococcus aureus infection	6/154	36/7206	9.90585476605e-05
ko04064	NF-kappa B signaling pathway	9/154	96/7206	0.000195400593664
ko04610	Complement and coagulation cascades	8/154	79/7206	0.000261772052778
ko04666	Fc gamma R-mediated phagocytosis	10/154	122/7206	0.000263029691594
ko04620	Toll-like receptor signaling pathway	9/154	100/7206	0.00026660607782
ko04660	T cell receptor signaling pathway	10/154	124/7206	0.000300265846006
ko05160	Hepatitis C	11/154	153/7206	0.000408435333626
ko05162	Measles	9/154	120/7206	0.00101996725065
ko05161	Hepatitis B	11/154	173/7206	0.00114303896082
ko05168	Herpes simplex infection	11/154	182/7206	0.00172210940764
ko05131	Shigellosis	7/154	82/7206	0.0017659202082
ko04137	Mitophagy - animal	7/154	82/7206	0.0017659202082
ko04622	RIG-I-like receptor signaling pathway	6/154	62/7206	0.00198051363239
ko05133	Pertussis	7/154	87/7206	0.00248393045117
ko04611	Platelet activation	10/154	163/7206	0.00249113790311
ko05323	Rheumatoid arthritis	7/154	89/7206	0.00282698723012
ko04068	FoxO signaling pathway	10/154	167/7206	0.00297259617403
ko04215	Apoptosis - multiple species	5/154	47/7206	0.00310811370776
ko04217	Necroptosis	10/154	178/7206	0.00468854296872
ko04670	Leukocyte transendothelial migration	9/154	151/7206	0.00491621249923
ko04664	Fc epsilon RI signaling pathway	6/154	77/7206	0.00588056741248
ko04672	Intestinal immune network for IgA production	4/154	37/7206	0.00765712319981
ko04933	AGE-RAGE signaling pathway in diabetic complications	8/154	135/7206	0.00814601534282
ko05215	Prostate cancer	7/154	111/7206	0.00944916629401
ko04623	Cytosolic DNA-sensing pathway	4/154	41/7206	0.0109943394205
ko05166	HTLV-I infection	13/154	292/7206	0.011073126371
ko05144	Malaria	4/154	45/7206	0.0151497422221
ko04066	HIF-1 signaling pathway	7/154	123/7206	0.0160046143278
ko01522	Endocrine resistance	7/154	124/7206	0.0166674008005
ko04015	Rap1 signaling pathway	12/154	278/7206	0.0178446718655
ko05132	Salmonella infection	6/154	98/7206	0.0181487620072
ko05152	Tuberculosis	9/154	187/7206	0.0185134229714
ko05142	Chagas disease (American trypanosomiasis)	7/154	130/7206	0.0210576089337
ko05140	Leishmaniasis	5/154	75/7206	0.0217496601948
ko04630	Jak-STAT signaling pathway	7/154	132/7206	0.022684785349
ko01524	Platinum drug resistance	5/154	76/7206	0.0228927725387
ko05340	Primary immunodeficiency	3/154	30/7206	0.0254838005026
ko05220	Chronic myeloid leukemia	5/154	85/7206	0.034947478541
ko04657	IL-17 signaling pathway	5/154	87/7206	0.0380719111276
ko04072	Phospholipase D signaling pathway	9/154	197/7206	0.0383608948804
ko04662	B cell receptor signaling pathway	5/154	88/7206	0.0396963668975
ko04062	Chemokine signaling pathway	9/154	201/7206	0.0402244743806
ko05169	Epstein-Barr virus infection	9/154	206/7206	0.0430349308087
ko04211	Longevity regulating pathway	6/154	123/7206	0.0477243209968